Posted inCardiology news Oncology
Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients
Elevated levels of inflammatory and cardiac biomarkers are linked to higher risks of venous thromboembolism and bleeding in cancer patients, according to a post hoc analysis of the AVERT trial.






